AzTrials
AzTrials

Idiopathic Parkinson's DiseaseNCT00261781

Walking Capacity in Parkinson's Disease (PD-Walk)

A study testing Treadmill training in people with Idiopathic Parkinson's Disease, run by Natalie Allen at 1 site in Australia.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The major aim of this study is to determine the efficacy of a home-based treadmill walking program in improving walking capacity and quality of life in people with early mid-stage Parkinson's disease(PD). Read more about this study

Who is it for?
Ages 30 to 80 years
Conditions the study is for
Idiopathic Parkinson's Disease
What is being tested?
Treadmill training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteAustralia
Study dates
May 2005to Sep 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • clinical diagnosis of idiopathic Parkinson's disease
  • aged 30-80 years old
  • subjective disturbance of gait and / or Unified Parkinson's disease rating scale (UPDRS) gait subscore of 1
  • sedentary, defined as performing less than 2 hours / week of leisure-time physical activity over the prior 3 months
  • have adapted to their current anti-Parkinsonian medication for at least 2 weeks

Who cannot join

  • motor fluctuations or dyskinesias which are disabling
  • require the use of a walking aid
  • more than one fall in the last 12 months
  • Mini-Mental State Examination score of <24
  • exhibit other neurological or musculoskeletal conditions affecting walking
  • chest pain at rest or during exercise in the last 3 months, or heart attack, angioplasty or heart surgery in the last 6 months

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Westmead Hospital

    Sydney, New South Wales, 2145

Other trials in Australia

About this study

Official title: Does Home-based Treadmill Training Improve Walking Capacity and Quality of Life in People With Early to Mid-stage Parkinson's Disease?

The major aim of this study is to determine the efficacy of a home-based treadmill walking program in improving walking capacity and quality of life in people with early mid-stage Parkinson's disease(PD).

Read the detailed description

After Alzheimer's disease, Parkinson's disease (PD) is the most common degenerative neurological condition suffered by Australians, with more than 30,000 Australians having PD at any one time (Parkinson's Australia). Hypokinesia, ie, reduced speed and amplitude of movement, is a major impairment of motor control affecting walking in people with PD. Over time, the development of slow, shuffling walking contributes to loss of independence and falls, with devastating consequences for individuals with PD and their families(Ashburn et al, 2001, Playfer 2001). Any decrease or delay in disability will reduce the personal and financial costs to individuals with PD, their families, health care resources and the community.

A number of previous studies suggest exercise capacity and exercise habits are positively correlated. In people with mild Parkinson's disease (Canning et al 2005), walking capacity, measured as distance walked in the 6-min walk test, correlated with the amount of walking (r=.64, p<0.01) performed each week. Similarly, in an earlier study of people with mild to moderate Parkinson's disease, regular exercise was associated with better exercise capacity (Canning et al 1997). It appears, therefore, that proactive intervention aimed at developing good exercise habits in sedentary individuals with early to mid-stage Parkinson's disease has the potential to reduce or delay walking difficulties.

This study aims to establish the efficacy of a home-based treadmill walking program in providing an early intervention which addresses the primary motor control impairment of hypokinesia, while at the same time maintaining or improving exercise capacity.

Being tested
Treadmill training
Keywords
Treadmill, Walking, Exercise, Automaticity, Quality of Life
Medical subject headings
Parkinson Disease, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treadmill trainingBehavioural

    Walking on a treadmill 3 times per week for 6 weeks

Study groups in NCT00261781
Study groupRoleWhat they receive
Treadmill trainingExperimentalHome-based treadmill training
Receives: Behavioral: Treadmill training
Usual careNo interventionControl group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Distance walked in 6 minutes

    Measured: study entry (0 weeks), 7 and 13 weeks

Secondary outcomes (4)
  1. Unified Parkinson's disease Rating Scale (UPDRS) - motor examination

    Measured: 0, 7 and 13 weeks

  2. The Parkinson's disease Questionnaire (PDQ-39

    Measured: 0, 7 and 13 weeks

  3. Walking Automaticity, determined as the velocity of walking 10m while performing a concurrent (cognitive or cognitive + physical) task expressed as a percentage of the velocity of walking 10m without performing the concurrent task.

    Measured: 0, 7 and 13 weeks

  4. Walking consistency determined as the co-efficients of variation for stride time and stride length recorded during the 6 minute walk test.

    Measured: 0, 7 and 13 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2005 (estimated)
  2. Study startMay 2005
  3. Primary completionDec 2006
  4. Study completionSep 2012

Why it stopped: 20 subjects completed for a pilot, further funding required to continue study

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00261781
Sponsor's protocol ID
U3189
Status last verified
May 2015
First submitted
1 Dec 2005
Last updated
29 May 2015
Results posted
No
Data monitoring committee
No

Publications

  • Ashburn A, Stack E, Pickering RM, Ward CD. A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing. 2001 Jan;30(1):47-52. doi: 10.1093/ageing/30.1.47.

    PubMed 11322672
  • Canning CG, Alison JA, Allen NE, Groeller H. Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait. Arch Phys Med Rehabil. 1997 Feb;78(2):199-207. doi: 10.1016/s0003-9993(97)90264-1.

    PubMed 9041903
  • Playfer JR. Falls and Parkinson's disease. Age Ageing. 2001 Jan;30(1):3-4. doi: 10.1093/ageing/30.1.3. No abstract available.

    PubMed 11322669
  • Canning CG, Allen NE, Dean CM, Goh L, Fung VS. Home-based treadmill training for individuals with Parkinson's disease: a randomized controlled pilot trial. Clin Rehabil. 2012 Sep;26(9):817-26. doi: 10.1177/0269215511432652. Epub 2012 Jan 18.

    PubMed 22257506

Questions about this trial

What is this clinical trial studying?

A study testing Treadmill training in people with Idiopathic Parkinson's Disease, run by Natalie Allen at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 29 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: 20 subjects completed for a pilot, further funding required to continue study). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Distance walked in 6 minutes (time frame: study entry (0 weeks), 7 and 13 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00261781, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in